Immunic, Inc. Research and Development Expense
Immunic, Inc. (IMUX) reported Research and Development Expense of $25.93 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-11
- Immunic, Inc. research and development expense for the quarter ending 2026-06-30 was $25.93M, a 21.35% increase year-over-year.
- Immunic, Inc. research and development expense for the quarter ending 2026-03-31 was $25.63M, a 19.01% increase year-over-year.
- Immunic, Inc. research and development expense for the quarter ending 2025-12-31 was $19.07M, a 11.79% decline year-over-year.
- Immunic, Inc. research and development expense for the quarter ending 2025-09-30 was $20.01M, a 6.35% decline year-over-year.
- Immunic, Inc. research and development expense for fiscal 2025 was $81.98M, a 2.42% increase from fiscal 2024.
- Immunic, Inc. research and development expense for fiscal 2024 was $80.05M, a 3.81% decline from fiscal 2023.
- Immunic, Inc. research and development expense for fiscal 2023 was $83.22M, a 16.78% increase from fiscal 2022.
- Immunic, Inc. research and development expense for fiscal 2022 was $71.25M, a 16.59% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed | Research and Development Expense 130 month |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $25.93M 10-Q · filed 2026-08-11 | $51.56M 10-Q · filed 2026-08-11 | $70.63M derived: sum of 3 quarters · filed 2026-08-11 | $90.64M derived: sum of 4 quarters · filed 2026-08-11 | |||||
| 2026-03-31 | $25.63M 10-Q · filed 2026-05-13 | $44.70M derived: sum of 2 quarters · filed 2026-05-13 | $64.71M derived: sum of 3 quarters · filed 2026-05-13 | $86.08M derived: sum of 4 quarters · filed 2026-08-11 | |||||
| 2025-12-31 | $19.07M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $39.08M derived: sum of 2 quarters · filed 2026-02-26 | $60.45M derived: sum of 3 quarters · filed 2026-08-11 | $81.98M 10-K · filed 2026-02-26 | |||||
| 2025-09-30 | $20.01M 10-Q · filed 2025-11-13 | $41.38M derived: sum of 2 quarters · filed 2026-08-11 | $62.91M 10-Q · filed 2025-11-13 | $84.53M derived: sum of 4 quarters · filed 2026-08-11 | |||||
| 2025-06-30 | $21.37M 10-Q · filed 2026-08-11 | $42.90M 10-Q · filed 2026-08-11 | $64.52M derived: sum of 3 quarters · filed 2026-08-11 | $85.89M derived: sum of 4 quarters · filed 2026-08-11 | |||||
| 2025-03-31 | $21.53M 10-Q · filed 2026-05-13 | $43.15M derived: sum of 2 quarters · filed 2026-05-13 | $64.52M derived: sum of 3 quarters · filed 2026-05-13 | $82.84M derived: sum of 4 quarters · filed 2026-05-13 | |||||
| 2024-12-31 | $21.62M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $42.99M derived: sum of 2 quarters · filed 2026-02-26 | $61.31M derived: sum of 3 quarters · filed 2026-02-26 | $80.05M 10-K · filed 2026-02-26 | |||||
| 2024-09-30 | $21.37M 10-Q · filed 2025-11-13 | $39.69M derived: sum of 2 quarters · filed 2025-11-13 | $58.43M 10-Q · filed 2025-11-13 | $77.71M derived: sum of 4 quarters · filed 2025-11-13 | |||||
| 2024-06-30 | $18.32M 10-Q · filed 2025-08-07 | $37.06M 10-Q · filed 2025-08-07 | $56.34M derived: sum of 3 quarters · filed 2025-08-07 | $76.14M derived: sum of 4 quarters · filed 2025-08-07 | |||||
| 2024-03-31 | $18.74M 10-Q · filed 2025-05-15 | $38.02M derived: sum of 2 quarters · filed 2025-05-15 | $57.82M derived: sum of 3 quarters · filed 2025-05-15 | $78.99M derived: sum of 4 quarters · filed 2025-05-15 | |||||
| 2023-12-31 | $19.28M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $39.08M derived: sum of 2 quarters · filed 2025-03-31 | $60.25M derived: sum of 3 quarters · filed 2025-03-31 | $83.22M 10-K · filed 2025-03-31 | |||||
| 2023-09-30 | $19.80M 10-Q · filed 2024-11-07 | $40.97M derived: sum of 2 quarters · filed 2024-11-07 | $63.93M 10-Q · filed 2024-11-07 | $84.67M derived: sum of 4 quarters · filed 2024-11-07 | |||||
| 2023-06-30 | $21.17M 10-Q · filed 2024-08-08 | $44.13M 10-Q · filed 2024-08-08 | $64.87M derived: sum of 3 quarters · filed 2024-08-08 | $81.41M derived: sum of 4 quarters · filed 2024-08-08 | |||||
| 2023-03-31 | $22.96M 10-Q · filed 2024-05-08 | $43.70M derived: sum of 2 quarters · filed 2024-05-08 | $60.23M derived: sum of 3 quarters · filed 2024-05-08 | $76.77M derived: sum of 4 quarters · filed 2024-05-08 | |||||
| 2022-12-31 | $20.73M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $37.27M derived: sum of 2 quarters · filed 2024-02-22 | $53.81M derived: sum of 3 quarters · filed 2024-02-22 | $71.25M 10-K · filed 2024-02-22 | |||||
| 2022-09-30 | $16.54M 10-Q · filed 2023-11-14 | $33.08M derived: sum of 2 quarters · filed 2023-11-14 | $50.52M 10-Q · filed 2023-11-14 | $68.90M derived: sum of 4 quarters · filed 2023-11-14 | |||||
| 2022-06-30 | $16.54M 10-Q · filed 2023-08-03 | $33.98M 10-Q · filed 2023-08-03 | $52.36M derived: sum of 3 quarters · filed 2023-08-03 | $67.84M derived: sum of 4 quarters · filed 2023-08-03 | |||||
| 2022-03-31 | $17.45M 10-Q · filed 2023-05-11 | $35.82M derived: sum of 2 quarters · filed 2023-05-11 | $51.30M derived: sum of 3 quarters · filed 2023-05-11 | $67.04M derived: sum of 4 quarters · filed 2023-05-11 | |||||
| 2021-12-31 | $18.38M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $33.86M derived: sum of 2 quarters · filed 2023-02-23 | $49.60M derived: sum of 3 quarters · filed 2023-02-23 | $61.12M 10-K · filed 2023-02-23 | |||||
| 2021-09-30 | $15.48M 10-Q · filed 2022-11-03 | $31.22M derived: sum of 2 quarters · filed 2022-11-03 | $42.74M 10-Q · filed 2022-11-03 | $53.91M derived: sum of 4 quarters · filed 2022-11-03 | |||||
| 2021-06-30 | $15.74M 10-Q · filed 2022-08-04 | $27.26M 10-Q · filed 2022-08-04 | $38.43M derived: sum of 3 quarters · filed 2022-08-04 | $49.47M derived: sum of 4 quarters · filed 2022-08-04 | |||||
| 2021-03-31 | $11.52M 10-Q · filed 2022-05-10 | $22.70M derived: sum of 2 quarters · filed 2022-05-10 | $33.73M derived: sum of 3 quarters · filed 2022-05-10 | $43.72M derived: sum of 4 quarters · filed 2022-05-10 | |||||
| 2020-12-31 | $11.18M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $22.22M derived: sum of 2 quarters · filed 2022-02-24 | $32.20M derived: sum of 3 quarters · filed 2022-02-24 | $38.64M 10-K · filed 2022-02-24 | |||||
| 2020-09-30 | $11.04M 10-Q · filed 2021-11-04 | $21.03M derived: sum of 2 quarters · filed 2021-11-04 | $27.46M 10-Q · filed 2021-11-04 | $33.49M derived: sum of 4 quarters · filed 2021-11-04 | |||||
| 2020-06-30 | $9.99M 10-Q · filed 2021-08-06 | $16.42M 10-Q · filed 2021-08-06 | $22.45M derived: sum of 3 quarters · filed 2021-08-06 | $29.55M derived: sum of 4 quarters · filed 2021-08-06 | |||||
| 2020-03-31 | $6.43M 10-Q · filed 2021-05-06 | $12.46M derived: sum of 2 quarters · filed 2021-05-06 | $19.56M derived: sum of 3 quarters · filed 2021-05-06 | $25.59M derived: sum of 4 quarters · filed 2021-05-06 | |||||
| 2019-12-31 | $6.03M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $13.13M derived: sum of 2 quarters · filed 2021-02-26 | $19.16M derived: sum of 3 quarters · filed 2021-02-26 | $22.51M 10-K · filed 2021-02-26 | |||||
| 2019-09-30 | $7.10M 10-Q · filed 2020-11-06 | $13.13M derived: sum of 2 quarters · filed 2020-11-06 | $16.49M 10-Q · filed 2020-11-06 | $20.73M derived: sum of 4 quarters · filed 2020-11-06 | |||||
| 2019-06-30 | $6.03M 10-Q · filed 2020-08-03 | $9.38M 10-Q · filed 2020-08-03 | $13.63M derived: sum of 3 quarters · filed 2020-08-03 | $15.04M derived: sum of 4 quarters · filed 2020-08-03 | |||||
| 2019-03-31 | $3.35M 10-Q · filed 2020-05-08 | $494.00K 10-Q · filed 2019-04-10 | $7.60M derived: sum of 2 quarters · filed 2020-05-08 | $9.01M derived: sum of 3 quarters · filed 2020-05-08 | $11.17M derived: sum of 4 quarters · filed 2020-05-08 | ||||
| 2018-12-31 | $4.25M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $5.66M derived: sum of 2 quarters · filed 2020-03-16 | $7.81M derived: sum of 3 quarters · filed 2020-03-16 | $9.60M 10-K · filed 2020-03-16 | $24.82M 10-K · filed 2019-03-04 | ||||
| 2018-09-30 | $1.41M 10-Q · filed 2019-11-07 | $5.99M 10-Q · filed 2018-11-08 | $3.57M derived: sum of 2 quarters · filed 2019-11-07 | $5.35M 10-Q · filed 2019-11-07 | $24.80M 10-Q · filed 2018-11-08 | $23.91M derived: sum of 4 quarters · filed 2019-11-07 | |||
| 2018-06-30 | $2.16M 10-Q · filed 2019-08-08 | $8.66M 10-Q · filed 2018-08-07 | $3.94M 10-Q · filed 2019-08-08 | $18.82M 10-Q · filed 2018-08-07 | $22.50M derived: sum of 3 quarters · filed 2019-08-08 | $32.19M derived: sum of 4 quarters · filed 2019-08-08 | |||
| 2018-03-31 | $10.16M 10-Q · filed 2019-04-10 | $20.35M derived: sum of 2 quarters · filed 2019-04-10 | $30.04M derived: sum of 3 quarters · filed 2019-04-10 | $39.87M derived: sum of 4 quarters · filed 2019-04-10 | |||||
| 2017-12-31 | $10.19M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-04 | $19.88M derived: sum of 2 quarters · filed 2019-03-04 | $29.71M derived: sum of 3 quarters · filed 2019-03-04 | $39.34M 10-K · filed 2019-03-04 | |||||
| 2017-09-30 | $9.69M 10-Q · filed 2018-11-08 | $19.52M derived: sum of 2 quarters · filed 2018-11-08 | $29.15M 10-Q · filed 2018-11-08 | $38.01M derived: sum of 4 quarters · filed 2019-03-04 | |||||
| 2017-06-30 | $9.83M 10-Q · filed 2018-08-07 | $19.46M 10-Q · filed 2018-08-07 | $28.32M derived: sum of 3 quarters · filed 2019-03-04 | $35.79M derived: sum of 4 quarters · filed 2019-03-04 | |||||
| 2017-03-31 | $9.63M 10-Q · filed 2018-05-08 | $18.49M derived: sum of 2 quarters · filed 2019-03-04 | $25.96M derived: sum of 3 quarters · filed 2019-03-04 | $32.82M derived: sum of 4 quarters · filed 2019-03-04 | |||||
| 2016-12-31 | $8.86M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-04 | $16.33M derived: sum of 2 quarters · filed 2019-03-04 | $23.19M derived: sum of 3 quarters · filed 2019-03-04 | $30.05M 10-K · filed 2019-03-04 | |||||
| 2016-09-30 | $7.47M 10-Q · filed 2017-10-25 | $14.33M derived: sum of 2 quarters · filed 2017-10-25 | $21.18M 10-Q · filed 2017-10-25 | $28.01M derived: sum of 4 quarters · filed 2018-03-13 | |||||
| 2016-06-30 | $6.86M 10-Q · filed 2017-08-03 | $13.71M 10-Q · filed 2017-08-03 | $20.54M derived: sum of 3 quarters · filed 2018-03-13 | $30.19M derived: sum of 4 quarters · filed 2018-03-13 | |||||
| 2016-03-31 | $6.86M 10-Q · filed 2017-05-09 | $13.69M derived: sum of 2 quarters · filed 2018-03-13 | $23.33M derived: sum of 3 quarters · filed 2018-03-13 | $34.88M derived: sum of 4 quarters · filed 2018-03-13 | |||||
| 2015-12-31 | $6.83M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | $16.47M derived: sum of 2 quarters · filed 2018-03-13 | $28.02M derived: sum of 3 quarters · filed 2018-03-13 | $39.77M 10-K · filed 2018-03-13 | |||||
| 2015-09-30 | $9.65M 10-Q · filed 2016-11-03 | $21.19M derived: sum of 2 quarters · filed 2016-11-03 | $32.95M 10-Q · filed 2016-11-03 | $43.83M derived: sum of 4 quarters · filed 2017-03-07 | |||||
| 2015-06-30 | $11.54M 10-Q · filed 2016-08-02 | $23.30M 10-Q · filed 2016-08-02 | $34.19M derived: sum of 3 quarters · filed 2017-03-07 | $44.43M derived: sum of 4 quarters · filed 2017-03-07 | |||||
| 2015-03-31 | $11.75M 10-Q · filed 2016-05-09 | $22.64M derived: sum of 2 quarters · filed 2017-03-07 | $32.89M derived: sum of 3 quarters · filed 2017-03-07 | $42.01M derived: sum of 4 quarters · filed 2017-03-07 | |||||
| 2014-12-31 | $10.89M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-07 | $21.13M derived: sum of 2 quarters · filed 2017-03-07 | $30.26M derived: sum of 3 quarters · filed 2017-03-07 | $39.48M 10-K · filed 2017-03-07 | |||||
| 2014-09-30 | $10.24M 10-Q · filed 2015-11-05 | $19.37M derived: sum of 2 quarters · filed 2015-11-05 | $28.59M 10-Q · filed 2015-11-05 | $36.24M derived: sum of 4 quarters · filed 2016-03-08 | |||||
| 2014-06-30 | $9.13M 10-Q · filed 2015-08-06 | $18.34M 10-Q · filed 2015-08-06 | $26.00M derived: sum of 3 quarters · filed 2016-03-08 | $32.16M derived: sum of 4 quarters · filed 2016-03-08 | |||||
| 2014-03-31 | $9.22M 10-Q · filed 2015-05-12 | $16.87M derived: sum of 2 quarters · filed 2016-03-08 | $23.04M derived: sum of 3 quarters · filed 2016-03-08 | $27.57M derived: sum of 4 quarters · filed 2016-03-08 | $72.20M 10-Q · filed 2014-05-28 | ||||
| 2013-12-31 | $7.65M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-08 | $13.82M derived: sum of 2 quarters · filed 2016-03-08 | $18.36M derived: sum of 3 quarters · filed 2016-03-08 | $21.79M 10-K · filed 2016-03-08 | |||||
| 2013-09-30 | $6.16M 10-Q · filed 2014-11-13 | $10.70M derived: sum of 2 quarters · filed 2014-11-13 | $14.13M 10-Q · filed 2014-11-13 | ||||||
| 2013-06-30 | $4.54M 10-Q · filed 2014-08-07 | $7.97M 10-Q · filed 2014-08-07 | |||||||
| 2013-03-31 | $3.43M 10-Q · filed 2014-05-28 | ||||||||
| 2012-12-31 | $5.10M 10-K · filed 2015-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B |